Literature DB >> 3305087

Clinical trial of gossypol as a male contraceptive drug. Part I. Efficacy study.

G Z Liu, K C Lyle, J Cao.   

Abstract

The main objective of the research is to study the effectiveness and safety of gossypol as a male contraceptive drug. Using a double-blind, randomized, controlled study design, gossypol was found to be an effective male antifertility drug, with no adverse effects on libido nor appetite. In terms of serum potassium levels, there were no statistical differences between gossypol and placebo groups at the end of the loading phase. However, through the ensuing 12 months of maintenance phase, a statistically significant trend toward reduced serum potassium level was evident.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraception Research; Contraceptive Agents, Male; Contraceptive Agents--side effects; Evaluation; Family Planning; Gossypol--side effects; Hemic System; Male Contraception; Physiology; Potassium Ion Level; Reproduction; Research Methodology; Spermatogenesis

Mesh:

Substances:

Year:  1987        PMID: 3305087     DOI: 10.1016/s0015-0282(16)59418-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

Review 1.  Effects of plants and plant products on the testis.

Authors:  Shereen Cynthia D'Cruz; Selvaraju Vaithinathan; Rajamanickam Jubendradass; Premendu Prakash Mathur
Journal:  Asian J Androl       Date:  2010-06-21       Impact factor: 3.285

Review 2.  An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease.

Authors:  D Wu
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

3.  A validated HPLC assay for the determination of R-(-)-gossypol in human plasma and its application in clinical pharmacokinetic studies.

Authors:  Hongxia Lin; Murugesan K Gounder; Joseph R Bertino; Ah-Ng Tony Kong; Robert S DiPaola; Mark N Stein
Journal:  J Pharm Biomed Anal       Date:  2012-03-24       Impact factor: 3.935

4.  High Throughput Screen Identifies Natural Product Inhibitor of Phenylalanyl-tRNA Synthetase from Pseudomonas aeruginosa and Streptococcus pneumoniae.

Authors:  Yanmei Hu; Stephanie O Palmer; Hector Munoz; James M Bullard
Journal:  Curr Drug Discov Technol       Date:  2014

Review 5.  Non-hormonal male contraception: A review and development of an Eppin based contraceptive.

Authors:  Michael G O'Rand; Erick J R Silva; Katherine G Hamil
Journal:  Pharmacol Ther       Date:  2015-11-22       Impact factor: 12.310

Review 6.  Advances in male contraception.

Authors:  Stephanie T Page; John K Amory; William J Bremner
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 7.  Update on Novel Hormonal and Nonhormonal Male Contraceptive Development.

Authors:  Jill E Long; Min S Lee; Diana L Blithe
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

8.  Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy.

Authors:  Ashiq Masood; Asfar S Azmi; Ramzi M Mohammad
Journal:  Cancers (Basel)       Date:  2011-06-01       Impact factor: 6.639

9.  The potentiality of medicinal plants as the source of new contraceptive principles in males.

Authors:  Ifeanyi Princewill Ogbuewu; Ihemdirim Chukwuma Unamba-Oparah; Victor Udodirim Odoemenam; Idorenyin Friday Etuk; Ifeanyi Charles Okoli
Journal:  N Am J Med Sci       Date:  2011-06

Review 10.  Emerging approaches to male contraception.

Authors:  Arthi Thirumalai; John K Amory
Journal:  Fertil Steril       Date:  2021-04-27       Impact factor: 7.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.